Friday, October 2, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchll-37cathelicidinantimicrobial peptidebiorxiv

Preprint: biphenyl motif boosts short LL-37 derivative potency 16-fold

Moving an N-terminal motif from full-length LL-37 onto a 12-residue core yielded FF-14, with greater membrane permeabilization against gram-negative bacteria.

PR
By Priya Raman · Science Reporter

The wire

  1. 01Authors transposed LL-37's N-terminal biphenyl motif onto the central activity region (residues 18-29), improving gram-negative activity more than 16-fold in the lead derivative FF-14.
  2. 02LL-37 is tracked closely on the immune-peptide beat; the work suggests shorter, cheaper cathelicidin analogs could approximate full-length activity.
  3. 03This is a bioRxiv preprint with in-vitro mechanistic work only; no animal efficacy, toxicity or stability-in-serum data are reported.

From the source

A portable N-terminal biphenyl motif in LL-37 enhances the activity of short human cathelicidin derivatives

bioRxiv : the preprint server for biology · 2026 Sep 25 · Albin JS, Vithanage DA, Johnson C et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →